AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2013
Jan 4, 2013
29828_dirs_2013-01-04_72e9334c-e8aa-4915-b755-34c1e88f7e0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-01-02
Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-02 | Common Stock | M | 68629 | $30.945 | Acquired | 103419 | Direct |
| 2013-01-02 | Common Stock | M | 44371 | $29.005 | Acquired | 147790 | Direct |
| 2013-01-02 | Common Stock | S | 65000 | $74.3494 | Disposed | 82790 | Direct |
| 2013-01-02 | Common Stock | S | 50000 | $75.00 | Disposed | 32790 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-02 | Non-Qualified Stock Option (right to buy) | $29.005 | M | 44371 | Disposed | 2016-01-25 | Common Stock (44371) | Direct |
| 2013-01-02 | Non-Qualified Stock Option (right to buy) | $30.945 | M | 68629 | Disposed | 2016-07-26 | Common Stock (68629) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Mr. Alton on October 26, 2012.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $73.93 to $74.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.